Maribel Salas, MD, DSc, FISPE

Executive Director
Bayr Pharmaceuticals Inc

Poster(s):

• (A-225) How are RWE/RWD used in pharmacovigilance for the development of oncologic products in early stages?
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-224) Towards Optimizing Identification of First Line of Therapy (LOT) for Metastatic Lung, Breast and Colorectal Cancer in Real World Data: A Scoping Review
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET